Pharmacological lipid modification therapy following stroke: an update-Reference-Cited by-同舟云学术

Pharmacological lipid modification therapy following stroke: an update

Published:2014-02-01 Issue:1 Volume:9 Page:83-89
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Mistri Amit K¹

Affiliation:

1. University Hospitals of Leicester NHS Trust, University of Leicester, Leicester Royal Infirmary, Leicester, LE1 5WW, UK

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.13.81

Reference46 articles.

1. Fonarow GC, Smith EE, Reeves MJ et al. Hospital‑level variation in mortality and rehospitalisation for Medicare beneficiaries with acute ischemic stroke. Stroke 42, 159–166 (2011).

2. Royal College of Physicians National Sentinel Stroke Clinical Audit 2010 Round 7 Public report for England, Wales and Northern Ireland. Prepared on behalf of the Intercollegiate Stroke Working Party May 2011 P43.

3. Adamson J, Beswick A, Shah E. Is stroke the most common cause of disability? J. Stroke Cerebrovasc. Dis. 13 (4), 171–177 (2004).

4. Mohan KM, Wolfe CDA, Rudd AG et al. Risk and cumulative risk of stroke recurrence: a systemic review and meta analysis. Stroke 42(5), 1489–1494 (2011).

5. Furie KL, Kasner SE, Adams RJ et al. Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42, 227–276 (2011). ▪▪ Comprehensive guidance from the American Heart Association/American Stroke Association covering all aspects of management of acute stroke.